Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

RVO

Categories

  • Care Pathway Roadmaps
  • Case Studies
  • CE Activities
  • Live CE Activities
  • On-Demand Education

Risk of Retinal Vein Occlusion (RVO) –52-Year-Old Male with a History of Poor Adherence to Hypertension and Dyslipidemia Therapy

December 12, 2023

FEATURING: Jordan Graff, MD, FACS, Dana McCormick, RPh, FAMCP

Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations Managed Care Pathway for Better Management of Retinal Vein Occlusion (RVO)

January 31, 2023

EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA

  • 1
  • 1-2 of 2 results
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

NEW Publication

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

Read Now